Rhythm Pharmaceuticals, Inc. (RYTM)
104.78
+4.07
(+4.04%)
USD |
NASDAQ |
Dec 10, 16:00
109.21
+4.43
(+4.23%)
After-Hours: 19:46
Rhythm Pharmaceuticals Total Assets (Quarterly): 506.87M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 58.53B |
| Terns Pharmaceuticals, Inc. | 301.65M |
| Altimmune, Inc. | 218.45M |
| Viking Therapeutics, Inc. | 739.42M |
| Cidara Therapeutics, Inc. | 518.65M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 358.06M |
| Shareholders Equity (Quarterly) | 148.82M |
| Debt to Equity Ratio | 1.747 |
| Current Ratio | 4.746 |
| Net Debt Paydown Yield | -0.02% |